Skip to main content
FinSpry Logo
FinSpry
PAHC logo
PAHC
(NASDAQ)
Phibro Animal Health Corporation
$33.81-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Phibro Animal Health (PAHC) Stock Price & Financial Analysis

Phibro Animal Health Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$33.75 - $34.81
52-Week High$60.08
52-Week Low$22.51
Open$34.10
Volume484.94K
Average Volume (3M)386.01K
Market Cap1.41B
Shares Outstanding40.96M
P/E Ratio (TTM)15.29
Forward P/E7.57
Price to Sales (P/S)0.96
Price to Book (P/B)4.24
EV/EBITDA9.41
Revenue (TTM)1.46B
Net Income (TTM)92.09M
Free Cash Flow (TTM)47.29M
EPS (TTM)$2.26
Profit Margin6.29%
Operating Margin11.53%
Return on Equity (ROE)27.71%
Debt to Equity2.20
50-Day MA$52.90
200-Day MA$43.17
52-Week Change48.24%
Annual Dividend$0.48
Dividend Yield1.40%
Payout Ratio21.27%
Last Dividend Ex-DateJun 3, 2026

Frequently Asked Questions About Phibro Animal Health

What is the current stock price for PAHC?

As of the latest trading session, PAHC stock trades at $33.81. The 52-week range is $22.51–$60.08, with a day range of $33.75–$34.81.

What is the P/E ratio for PAHC?

Phibro Animal Health's trailing P/E ratio is 15.3, meaning investors pay $15.3 for every $1 of annual earnings. The forward P/E is 7.6, reflecting analyst expectations for future earnings. Phibro Animal Health operates in the Healthcare sector.

Does PAHC pay dividends?

Yes, Phibro Animal Health pays a 1.40% annual dividend yield ($0.48 per share). The payout ratio is 21.3%. The last ex-dividend date was 2026-06-03.

What do analysts recommend for PAHC?

Based on 1 analyst, the consensus for PAHC is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of PAHC?

Phibro Animal Health's market capitalization is $1.38B, classifying it as a small-cap company. Phibro Animal Health operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.